HomeRLMD • NASDAQ
add
Relmada Therapeutics Inc
Previous close
$3.86
Day range
$3.66 - $3.81
Year range
$2.36 - $7.22
Market cap
111.64M USD
Avg Volume
175.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 26.83M | -30.68% |
Net income | -25.17M | 33.68% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 96.32M | -35.06% |
Total assets | 97.55M | -36.20% |
Total liabilities | 12.19M | -2.20% |
Total equity | 85.36M | — |
Shares outstanding | 30.17M | — |
Price to book | 1.36 | — |
Return on assets | -64.90% | — |
Return on capital | -72.09% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -25.17M | 33.68% |
Cash from operations | -10.25M | 71.44% |
Cash from investing | 7.74M | 567.62% |
Cash from financing | -98.46K | -124.02% |
Net change in cash | -2.61M | 92.98% |
Free cash flow | -1.45M | 93.53% |
About
Founded
2012
Headquarters
Website
Employees
20